NDC 65219-862 – Ustekinumab-aauz
Ustekinumab 45 mg/.5mL · Injection, Solution · Subcutaneous
Product NDC65219-862
Product details
- Brand name
- Ustekinumab-aauz
- Generic name
- Ustekinumab-aauz
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761379
- Marketed since
- November 15, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab 45 mg/.5mL
Uses, dosage, side effects and warnings for Ustekinumab-aauz →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 65219-862-01 | 1 SYRINGE in 1 CARTON (65219-862-01) / .5 mL in 1 SYRINGE | Nov 15, 2025 |
Other Ustekinumab-aauz products
- 65219-866 Ustekinumab 90 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC